RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Nathaniel E. Eraikhuemen to Thrombosis

Back to Details
This is a "connection" page, showing publications Nathaniel E. Eraikhuemen has written about Thrombosis.
Nathaniel E. Eraikhuemen
Connection Strength
0.929
Thrombosis
  1. Lazaridis D, Leung S, Kohler L, Smith CH, Kearson ML, Eraikhuemen N. The Impact of Anticoagulation on COVID-19 (SARS CoV-2) Patient Outcomes: A Systematic Review. J Pharm Pract. 2022 Dec; 35(6):1000-1006.
    View in: PubMed
    Score: 0.744
  2. Eraikhuemen N, Lazaridis D, Dutton MT. Emerging Pharmacotherapy to Reduce Elevated Lipoprotein(a) Plasma Levels. Am J Cardiovasc Drugs. 2021 May; 21(3):255-265.
    View in: PubMed
    Score: 0.186
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support